Yoshida H
Fourth Department of Medicine, School of Medicine, Toho University, Tokyo, Japan.
Nihon Naibunpi Gakkai Zasshi. 1988 Jul 20;64(7):547-53. doi: 10.1507/endocrine1927.64.7_547.
Although the presence of bone abnormalities has been well known in myotonic dystrophy (MyD), details about calcium metabolism in this condition remain unclear. We already reported that the intestinal calcium absorption is increased in MyD patients due to the elevation of plasma 1,25(OH)2D level. We also reported that serum immunoreactive parathyroid hormone (iPTH) levels and Nephrogenous cyclic AMP (NcAMP) levels are increased in MyD patients. This study was designed to elucidate the mechanism of hyperparathyroid state in MyD patients. Intravenous calcium tolerance test was performed in 7 patients with MyD and 7 control subjects, 3 patients with other neuromuscular disorder and 4 healthy subjects. Calcium was infused stepwise at the concentration of 0, 104.7, 194.9 and 235.5mg every hour. The basal plasma calcium levels were significantly higher in MyD (9.79 +/- 0.27 mg/dl, Mean +/- SD) as compared with control subjects (9.50 +/- 0.19; p less than 0.05). Basal serum iPTH levels were also significantly higher in MyD (514.0 +/- 188.9 pg/ml) than those in control subjects (333.7 +/- 113.5; p less than 0.05). After calcium infusion, serum calcium levels were increased in both groups, but the levels of serum calcium remained significantly higher in MyD than those in control subjects. On the other hand, urinary calcium excretion levels were not different between the two groups. At the same time, %TRP and calcium clearance were significantly lower in MyD than control subjects.(ABSTRACT TRUNCATED AT 250 WORDS)
尽管强直性肌营养不良(MyD)患者存在骨骼异常已为人熟知,但该病症中钙代谢的细节仍不清楚。我们已经报道,由于血浆1,25(OH)2D水平升高,MyD患者的肠道钙吸收增加。我们还报道,MyD患者的血清免疫反应性甲状旁腺激素(iPTH)水平和肾源性环磷酸腺苷(NcAMP)水平升高。本研究旨在阐明MyD患者甲状旁腺功能亢进状态的机制。对7例MyD患者、7例对照受试者、3例其他神经肌肉疾病患者和4例健康受试者进行了静脉钙耐量试验。每小时以0、104.7、194.9和235.5mg的浓度逐步输注钙。与对照受试者(9.50 +/- 0.19;p < 0.05)相比,MyD患者的基础血浆钙水平显著更高(9.79 +/- 0.27mg/dl,平均值 +/- 标准差)。MyD患者的基础血清iPTH水平(514.0 +/- 188.9pg/ml)也显著高于对照受试者(333.7 +/- 113.5;p < 0.05)。输注钙后,两组的血清钙水平均升高,但MyD患者的血清钙水平仍显著高于对照受试者。另一方面,两组的尿钙排泄水平没有差异。同时,MyD患者的%TRP和钙清除率显著低于对照受试者。(摘要截断于250字)